Targeting the metabolic drivers of disease.
Location: United States, Massachusetts, Boston
Employees: 1-10
Founded date: 2016
Investors 7
Mentions in press and media 3
| Date | Title | Description |
| 18.03.2020 | Saving lives should be good business. Why doesn’t that apply to finding new antibiotics? | I have spent my career as a biomedical entrepreneur working to develop products that have the potential to save lives while also generating returns for shareholders. Two years ago, I co-founded a new company, Octagon Therapeutics, focused o... |
| 15.02.2018 | Octagon Therapeutics Closes Financing Round | Octagon Therapeutics, a Cambridge, MA-based preclinical-stage biopharmaceutical company developing antibiotics for multi-drug resistant infections, closed a seed financing round of undisclosed round. Backers included from a group of angel i... |
| 23.05.2017 | MassChallenge Boston Announces 2017 Cohort | BOSTON, MAY 23, 2017 - MassChallenge, the most startup-friendly accelerator on the planet, today announced the 128 early-stage startups that have been accepted into the 2017 MassChallenge Boston accelerator program. Selected by a community ... |